GUELPH, ON, Aug. 26, 2024 /CNW/ - BIOREM Inc. (TSXV:BRM) ("Biorem" or "the Company") today announced its results for the three and six-month periods ended June 30, 2024. Biorem's complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
FINANCIAL HIGHLIGHTS:
in Canadian dollars, '000's except earnings per share
Three-months ended
Six -months ended
June 30
June 30
2024
2023
2024
2023
Revenue
7,300
4,280
13,218
7,449
Gross profit
1,657
954
3,437
1,070
Operating expenses